| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Brenner Malcolm is a Director at Kalaris Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 35 sells.
Estimated insider holdings value: $441K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 5, 2021 | KLRS Kalaris Therapeutics, Inc. | Director | Sell | 97,689 | $33.50 | $3,272,798.11 | -1.3% | |
| Mar 3, 2021 | KLRS Kalaris Therapeutics, Inc. | Director | Sell | 52,267 | $38.28 | $2,000,565.35 | -0.7% | |
| Feb 23, 2021 | KLRS Kalaris Therapeutics, Inc. | Director | Sell | 31,902 | $41.45 | $1,322,217.19 | -0.4% | |
| Feb 18, 2021 | KLRS Kalaris Therapeutics, Inc. | Director | Sell | 6,757 | $40.75 | $275,365.77 | -0.2% | |
| Feb 17, 2021 | KLRS Kalaris Therapeutics, Inc. | Director | Sell | 11,385 | $41.22 | $469,256.95 | -0.2% |